| 2026-08-11 | Press release | Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity |
| 2026-08-11 | Press release | Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity |
| 2026-07-23 | Press release | Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH |
| 2026-07-23 | Press release | Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH |
| 2026-07-14 | Press release | Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility |
| 2026-07-14 | Press release | Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility |
| 2026-07-02 | Press release | Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-07-02 | Press release | Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-05-20 | Presentation | May 2026 |
| 2026-05-12 | Press release | Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity |
| 2026-05-12 | Press release | Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity |
| 2026-05-12 | Press release | PDF |
| 2026-04-07 | Press release | Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Trea |
| 2026-04-07 | Press release | Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Trea |
| 2026-04-03 | Press release | Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-04-03 | Press release | Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-26 | Press release | Earnings Release |
| 2026-03-26 | Press release | Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity |
| 2026-03-26 | Press release | HTML |
| 2026-03-26 | Press release | PDF |
| 2025-11-20 | Press release | Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants |
| 2025-11-20 | Press release | Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants |
| 2025-11-20 | Press release | Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension |
| 2025-11-20 | Press release | Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants |
| 2025-11-20 | Press release | Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants |
| 2025-11-20 | Press release | Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension |
| 2025-11-14 | Press release | PDF |
| 2025-08-14 | Press release | PDF |
| 2025-05-14 | Press release | PDF |
| 2025-03-27 | Press release | PDF |
| 2024-11-14 | Press release | Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity |
| 2024-11-14 | Press release | Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity |
| 2024-11-14 | Press release | PDF |
| 2024-08-14 | Press release | Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity |
| 2024-08-14 | Press release | Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity |
| 2024-08-14 | Press release | PDF |
| 2024-08-07 | Press release | Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 |
| 2024-08-07 | Press release | Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 |
| 2024-05-15 | Press release | Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity |
| 2024-05-15 | Press release | Earnings Release |